Codesigning a social prescribing pathway to address the social determinant of health concerns of children with cerebral palsy and their families in Australia: a protocol for a mixed-methods formative research study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
06 04 2023
Historique:
medline: 10 4 2023
entrez: 6 4 2023
pubmed: 7 4 2023
Statut: epublish

Résumé

Social determinants of health (SDH) are contributors to health inequities experienced by some children with cerebral palsy and pose barriers to families engaging with complex and fragmented healthcare systems. There is emerging evidence to support 'social prescribing' interventions that systematically identify SDH concerns and refer patients to non-medical social care support and services to address their needs. To date, social prescribing has not been trialled specifically for children with neurodevelopmental disabilities, including cerebral palsy, in Australia. This study aims to codesign a social prescribing programme to address SDH concerns of children with cerebral palsy and their families who attend one of the three tertiary paediatric rehabilitation services in New South Wales, Australia. This is a qualitative multi-site study conducted at the three NSW paediatric hospitals' rehabilitation departments using a codesign approach. Children aged 12-18 years with cerebral palsy, parents/caregivers of children (aged 0-18 years) with cerebral palsy, and clinicians will be involved in all stages to codesign the social prescribing programme. The study will consist of three components: (1) 'what we need', (2) 'creating the pathways' and (3) 'finalising and sign off'. This project is overseen by two advisory groups: one group of young adults with cerebral palsy and one group of parents of young people with cerebral palsy. The study will be guided by the biopsychosocial ecological framework, and analysis will follow Braun and Clark's thematic approach. The study protocol was approved by the human research ethics committee of the Sydney Children's Hospitals Network. This codesign study will inform a future pilot study of feasibility and acceptability, then if indicated, a pilot clinical trial of efficacy. We will collaborate with all project stakeholders to disseminate findings and undertake further research to build sustainable and scalable models of care. ACTRN12622001459718.

Identifiants

pubmed: 37024248
pii: bmjopen-2022-066346
doi: 10.1136/bmjopen-2022-066346
pmc: PMC10083805
doi:

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e066346

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Dev Med Child Neurol. 2021 Oct;63(10):1132
pubmed: 34490621
Dev Med Child Neurol. 2022 Sep;64(9):1106-1113
pubmed: 35244200
BMC Public Health. 2017 Sep 4;17(1):689
pubmed: 28870192
Int J Environ Res Public Health. 2022 Jan 27;19(3):
pubmed: 35162458
Disabil Rehabil. 2014;36(3):210-9
pubmed: 23627535
Pediatrics. 2015 Feb;135(2):e296-304
pubmed: 25560448
BMJ Open. 2019 Aug 15;9(8):e029954
pubmed: 31420394
J Paediatr Child Health. 2018 Aug;54(8):832-833
pubmed: 30133886
BMC Public Health. 2018 Feb 20;18(1):270
pubmed: 29458355
Aust Occup Ther J. 2022 Dec;69(6):653-661
pubmed: 35599379
Paediatr Child Health. 2014 Apr;19(4):195-9
pubmed: 24855416
BMJ Open. 2017 Apr 7;7(4):e013384
pubmed: 28389486
Lancet. 1971 Feb 27;1(7696):405-12
pubmed: 4100731
J Child Neurol. 2014 May;29(5):582-91
pubmed: 23435282
Dev Med Child Neurol. 2016 Feb;58 Suppl 2:50-6
pubmed: 26777873
Dev Med Child Neurol. 2016 Feb;58(2):160-6
pubmed: 26010819
J Epidemiol Community Health. 2006 Oct;60(10):854-7
pubmed: 16973531
J Paediatr Child Health. 2021 May;57(5):631-636
pubmed: 33426739
BMJ Open. 2020 Nov 3;10(11):e038339
pubmed: 33148733
Dev Med Child Neurol. 2007 Feb;49(s109):1-44
pubmed: 17371509
JAMA Pediatr. 2016 Nov 7;170(11):e162521
pubmed: 27599265
Clin Pediatr (Phila). 2009 Jan;48(1):32-6
pubmed: 18566347
Pediatrics. 2004 Jun;113(6 Suppl):1934-43
pubmed: 15173464
J Autism Dev Disord. 2019 Jul;49(7):2923-2934
pubmed: 31016675
Health Res Policy Syst. 2020 Feb 11;18(1):17
pubmed: 32046728
Int J Circumpolar Health. 2018 Dec;77(1):1466604
pubmed: 29697022
BMJ Qual Saf. 2016 Sep;25(9):716-25
pubmed: 26647411
Dev Med Child Neurol. 2019 May;61(5):586-592
pubmed: 30221759
Arch Phys Med Rehabil. 2022 Aug;103(8):1628-1637
pubmed: 34968439

Auteurs

Katarina Ostojic (K)

Population Child Health Research Group, University of New South Wales, Sydney, New South Wales, Australia k.ostojic@unsw.edu.au.

Simon Paget (S)

Kids Rehab, Children's Hospital at Westmead, Westmead, New South Wales, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Tanya Martin (T)

Sydney Medical School, University of Sydney Poche Centre for Indigenous Health, Camperdown, New South Wales, Australia.

Betty-Jean Dee-Price (BJ)

College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.

Sarah McIntyre (S)

Cerebral Palsy Alliance Research Institute, Specialty of Child & Adolescent Health, The University of Sydney, Sydney, New South Wales, Australia.

Hayley Smithers Sheedy (H)

Cerebral Palsy Alliance Research Institute, Specialty of Child & Adolescent Health, The University of Sydney, Sydney, New South Wales, Australia.

Laurel Mimmo (L)

Population Child Health Research Group, University of New South Wales, Sydney, New South Wales, Australia.
Nursing Research Unit, The Sydney Children's Hospitals Network, Sydney, New South Wales, Australia.

Heather Burnett (H)

John Hunter Children's Hospital, Hunter Region Mail Centre, New South Wales, Australia.

Timothy Scott (T)

Rehab2Kids, Sydney Children's Hospital, Randwick, New South Wales, Australia.

Alison Berg (A)

Kids Rehab, Children's Hospital at Westmead, Westmead, New South Wales, Australia.

Anne Masi (A)

School of Psychiatry, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.

Michele Scarcella (M)

Aboriginal Health, Sydney Children's Hospitals Network, Sydney, New South Wales, Australia.

Jack Calderan (J)

EPIC-CP Research Group, University of New South Wales, Sydney, New South Wales, Australia.

Sheikh Azmatullah (S)

EPIC-CP Research Group, University of New South Wales, Sydney, New South Wales, Australia.

Masyitah Mohamed (M)

EPIC-CP Research Group, University of New South Wales, Sydney, New South Wales, Australia.

Mackenzie Woodbury (M)

EPIC-CP Research Group, University of New South Wales, Sydney, New South Wales, Australia.

Alunya Wilkinson (A)

EPIC-CP Research Group, University of New South Wales, Sydney, New South Wales, Australia.

Karen Zwi (K)

Population Child Health Research Group, University of New South Wales, Sydney, New South Wales, Australia.
Community Child Health, Sydney Children's Hospitals Network Randwick and Westmead, Sydney, New South Wales, Australia.

Russell Dale (R)

Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Kids Neuroscience Centre, Kids Research, Children's Hospital at Westmead, Westmead, New South Wales, Australia.

Valsamma Eapen (V)

School of Psychiatry, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.

Raghu Lingam (R)

Population Child Health Research Group, University of New South Wales, Sydney, New South Wales, Australia.

Iva Strnadová (I)

School of Education, University of New South Wales, Sydney, New South Wales, Australia.
Disability Innovation Institute, University of New South Wales, Sydney, New South Wales, Australia.

Susan Woolfenden (S)

Population Child Health Research Group, University of New South Wales, Sydney, New South Wales, Australia.
Community Paediatrics Research Group, Institute for Women, Children and Families, Sydney Local Health District, Camperdown, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH